With extensive experience in the technology and healthcare sectors, the fund manager has successfully executed over 30 deals across North America and Europe. Their investment strategy emphasizes a data-driven approach, targeting growth-stage companies poised for significant market disruption. Notable exits have included leading firms in biotech and SaaS, showcasing a strong ability to identify lucrative opportunities. This operator-first style ensures deep operational insights and strategic guidance, facilitating robust portfolio development.